| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01688791 2012-002799-14 Details | 2015-02-10 Interventional | 1 | 37 | Carboplatin Paclitaxel Neoplasms Advanced Cancer | - - | |||
| NCT01010373 Details | 2015-02-10 Interventional | 2 | - | Ammonium trichl… Leukemia Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Preleukemia Syndrome Acute Myeloid L… Myelodysplastic… | The sponsor is currently focusing on different indications - | |||
| NCT02358642 Details | 2015-02-09 Interventional | 4 | 93 | Angiotensin-Con… Enzyme Inhibito… Lisinopril Deglutition Dis… Pneumonia Neurological Dy… | The interim analysis suggested that low dose lisinopril given to be tube fed older patients
with neuroligical dysphagia had increased mortality. - | |||
| NCT00453453 Details | 2015-02-09 Interventional | 4 | 17 | Natriuretic Pep… Heart Failure Congestive Hear… | - - | |||
| NCT02048358 2013-004077-28 Details | 2015-02-06 Interventional | 1 | 47 | Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Multiple Sclero… Sclerosis Healthy Volunte… | - - | |||
| NCT01352702 2011-000504-18 Details | 2015-02-05 Interventional | 4 | 46 | Dabigatran Phenprocoumon Acute Coronary … Atherosclerosis Atrial Fibrilla… Coronary Artery… Coronary Diseas… Heart Diseases Myocardial Isch… Coronary Heart … | Slow recruitment; Study was terminated for futility reasons - | |||
| NCT00539968 Details | 2015-02-05 Interventional | 1/2 | 5 | Docetaxel Lonafarnib Breast Cancer Gastric Cancer Lung Cancer Ovarian Cancer Prostate Cancer | - - | |||
| NCT00420589 Details | 2015-02-05 Interventional | 3 | [1 Refs] | 1000 | N-(3-(4-chlorop… Obesity | The overall profile does not support development for obesity - | ||
| NCT00131404 Details | 2015-02-05 Interventional | 3 | [1 Refs] | 2400 | N-(3-(4-chlorop… Obesity | The overall profile does not support development for obesity - | ||
| NCT01813656 Details | 2015-02-04 Interventional | 4 | 10 | Aripiprazole Methamphetamine… | Aripiprazole arm had obvious adverse reactions,especially akathisia. - | |||
| NCT01813643 Details | 2015-02-04 Interventional | 4 | 50 | Aripiprazole Risperidone Methamphetamine… | Effects of aripiprazole was not obvious and showed adverse reaction obviously - | |||
| NCT01275976 Details | 2015-02-04 Interventional | 3 | 11 | Complement C1 I… Complement C1 I… Complement C1s Hip Fractures Inflammation Multiple Organ … Wounds and Inju… Multiple Organ … Sepsis Trauma | Futility and limited feasibility - | |||
| NCT00913003 Details | 2015-02-04 Interventional | 4 | 22 | Lidocaine Pain | PI terminated employment with the University This study was terminated early because the PI left the institution. | |||
| NCT00798213 Details | 2015-02-04 Interventional | 2 | [1 Refs] | 29 | Gemtuzumab Leukemia Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Precursor Cell … Lymphoblastic L… | - - | ||
| NCT01762670 Details | 2015-02-03 Interventional | 1/2 | 8 | Metronidazole Vaginal Disease… Vaginosis, Bact… Bacterial Vagin… | Company decided to stop study for reasons other than safety - | |||
| NCT01417403 Details | 2015-02-03 Interventional | 1 | 10 | Hydroxychloroqu… Bone Marrow Dis… Bone Neoplasms Neoplasm Metast… Bone Metastases Unspecified Adu… | Recently published data that has shown HCQ to be safe when combined with chemo and or radiation
at even higher doses than what is used in this study. - | |||
| NCT02271347 Details | 2015-02-02 Interventional | 2 | 0 | Brincidofovir Hemorrhagic Fev… Virus Diseases Ebola Virus | Suspended Development Program - | |||
| NCT00500006 Details | 2015-01-30 Interventional | 1 | [1 Refs] | 3 | Dasatinib Leukemia Leukemia, Myelo… Leukemia, Myelo… Philadelphia Ch… Precursor Cell … Chronic Myeloge… Leukemia, Lymph… | - - | ||
| NCT01803399 Details | 2015-01-28 Interventional | 1 | 0 | Moxifloxacin Bacterial Infec… Infections, Bac… | Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen
that changed the risk: benefit profile and led to a termination - | |||
| NCT01103713 Details | 2015-01-26 Interventional | 3 | 168 | Azithromycin Chloroquine Parasitemia Asymptomatic Pa… | See termination reason in detailed description. - |